Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program. - Weinstock A; Bebin EM; Checketts D; Clark GD; Szaflarski JP; Seltzer LE; Thiele EA; Sahebkar F (Epilepsia open, 2024)